IL17B Protein (AA 21-180) (Fc Tag)
-
- Antigène Voir toutes IL17B Protéines
- IL17B (Interleukin 17B (IL17B))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 21-180
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette IL17B protéine est marqué à la Fc Tag.
- Fonction
- Human IL-17B Protein
- Séquence
- Gln21-Phe180
- Attributs du produit
- Recombinant Human IL-17B Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Gln21-Phe180.
- Pureté
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- Stérilité
- 0.22 μm filtered
- niveau d'endotoxine
- Less than 1EU per μg by the LAL method.
- Top Product
- Discover our top product IL17B Protéine
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- IL17B (Interleukin 17B (IL17B))
- Autre désignation
- IL-17B (IL17B Produits)
- Synonymes
- il-17b Protein, il-20 Protein, zcyto7 Protein, IL17B Protein, IL-17B Protein, IL-20 Protein, NIRF Protein, ZCYTO7 Protein, 1110006O16Rik Protein, 1700006N07Rik Protein, Zcyto7 Protein, interleukin 17B Protein, interleukin 17B L homeolog Protein, IL17B Protein, il17b Protein, il17b.L Protein, Il17b Protein
- Sujet
- IL-17A, the prototypic member of the IL-17 family, several experimental findings strongly support the role of the IL-17B/IL-17 receptor B (IL-17RB) pathway in tumorigenesis and resistance to anticancer therapies. IL-17B/IL-17RB expression patterns and biological activities in cancer and highlight issues that remain to be addressed to better characterize IL-17B and its receptor as potential targets for enhancing the effectiveness of the existing cancer therapies.
- Poids moléculaire
- 44.91 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Tris-Bis PAGE result.
- UniProt
- Q9UHF5
-